Cập nhật pháp chế
28 thg 9, 2026•1 phút đọc
FDA Approves ANDA083919 for MILTOWN Oral Tablet (Meprobamate 600 mg)
The FDA has approved application ANDA083919 for MILTOWN, an oral tablet containing 600 mg of meprobamate, sponsored by Medpointe Pharm HLC.
Cập nhật pháp chế
23 thg 9, 2026•1 phút đọc
SOLVAY's TRANMEP Tablet (Meprobamate 400mg) Discontinued – ANDA084369
FDA records show SOLVAY's oral tablet TRANMEP, containing 400 mg meprobamate, is listed as discontinued under application ANDA084369.
Cập nhật pháp chế
19 thg 9, 2026•1 phút đọc
FDA Approves ANDA083442 for Meprobamate 400mg Oral Tablet
The FDA approved ANDA083442 for a 400 mg oral tablet of meprobamate submitted by Whiteworth Town Plsn; the product is listed as discontinued.
Cập nhật pháp chế
10 thg 9, 2026•1 phút đọc
MEPROBAMATE (ANDA 085721) Discontinued Oral Tablet – FDA
FDA records show the oral tablet MEPROBAMATE (400 mg) is discontinued, with multiple manufacturing and labeling submissions approved between 1983 and 1999.
Cập nhật pháp chế
31 thg 8, 2026•1 phút đọc
FDA Approves ANDA 084030 for Amosene 400 mg Meprobamate Tablet
The FDA approved ANDA 084030 for the oral tablet Amosene, a 400 mg meprobamate product submitted by FernDale Labs. The listing notes the product as discontinued.
Cập nhật pháp chế
30 thg 8, 2026•1 phút đọc
FDA Approves ANDA 084744 for Meprobamate Oral Tablets (200 mg & 400 mg)
The FDA approved ANDA 084744 on Dec 9 1975 for Meprobamate tablets (200 mg and 400 mg) marketed by Parke Davis, now listed as discontinued.
Cập nhật pháp chế
25 thg 8, 2026•1 phút đọc
FDA Approves ANDA080699 for Meprobamate Oral Tablets
The FDA granted approval for SUN PHARM INDUSTRIES' ANDA080699 covering oral Meprobamate tablets (200 mg and 400 mg). Multiple manufacturing and labeling submissions were approved between 1986 and 1998; the products are now discontinued.